{"id":341715,"date":"2025-08-20T15:32:45","date_gmt":"2025-08-20T15:32:45","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-illumina\/"},"modified":"2025-08-20T15:32:45","modified_gmt":"2025-08-20T15:32:45","slug":"how-to-buy-illumina","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/","title":{"rendered":"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-341715","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Illumina, Inc. (ILMN) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve genomik dizileme pazar liderine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. 2025-2030 i\u00e7in g\u00fcncel fiyat, riskler ve b\u00fcy\u00fcme f\u0131rsatlar\u0131n\u0131 ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Illumina, Inc. (ILMN) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve genomik dizileme pazar liderine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. 2025-2030 i\u00e7in g\u00fcncel fiyat, riskler ve b\u00fcy\u00fcme f\u0131rsatlar\u0131n\u0131 ke\u015ffedin."},"intro":"\u0130nsan sa\u011fl\u0131\u011f\u0131n\u0131n gelece\u011fini \u00e7\u00f6zen \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Illumina sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014klinik genomikte %90'dan fazla pazar pay\u0131na sahip tart\u0131\u015fmas\u0131z liderdir. Kanser tedavisinden ki\u015fiselle\u015ftirilmi\u015f t\u0131bba kadar her \u015feyi devrim niteli\u011finde de\u011fi\u015ftiren teknolojileriyle, DNA devriminin bir par\u00e7as\u0131na sahip olma \u015fans\u0131n\u0131z burada. Illumina hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve neden 2025'in m\u00fckemmel bir giri\u015f noktas\u0131 olabilece\u011fini detayl\u0131ca a\u00e7\u0131klayaca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130nsan sa\u011fl\u0131\u011f\u0131n\u0131n gelece\u011fini \u00e7\u00f6zen \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Illumina sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014klinik genomikte %90'dan fazla pazar pay\u0131na sahip tart\u0131\u015fmas\u0131z liderdir. Kanser tedavisinden ki\u015fiselle\u015ftirilmi\u015f t\u0131bba kadar her \u015feyi devrim niteli\u011finde de\u011fi\u015ftiren teknolojileriyle, DNA devriminin bir par\u00e7as\u0131na sahip olma \u015fans\u0131n\u0131z burada. Illumina hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve neden 2025'in m\u00fckemmel bir giri\u015f noktas\u0131 olabilece\u011fini detayl\u0131ca a\u00e7\u0131klayaca\u011f\u0131z."},"body_html":"<h2>\ud83d\udcc8 Illumina Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla Illumina, Inc. (ILMN) NASDAQ'ta <strong>100,53 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>3 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014Illumina'n\u0131n 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu raporlar hisse senedini dramatik \u015fekilde hareket ettirmi\u015ftir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131n\u0131n ILMN Hissesini Hareket Ettirme \u015eekli<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>31 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>98,15 $<\/td><td><strong>%17,8 EPS s\u00fcrprizi<\/strong><\/td><\/tr> <tr><td>1 May\u0131s 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>94,50 $<\/td><td>%5,2 art\u0131\u015f (istikrarl\u0131 b\u00fcy\u00fcme)<\/td><\/tr> <tr><td>12 \u015eubat 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>102,30 $<\/td><td>%3,8 d\u00fc\u015f\u00fc\u015f (gelir hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>4 Kas\u0131m 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>105,60 $<\/td><td>%6,1 art\u0131\u015f (klinik b\u00fcy\u00fcme)<\/td><\/tr> <tr><td>8 A\u011fustos 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>108,90 $<\/td><td>%4,2 d\u00fc\u015f\u00fc\u015f (finansman endi\u015feleri)<\/td><\/tr> <tr><td>9 May\u0131s 2024<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>112,40 $<\/td><td>%3,5 art\u0131\u015f (yeni \u00fcr\u00fcn lansman\u0131)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Analizi<\/strong>: Illumina genellikle kazan\u00e7 s\u00fcrprizlerine g\u00fc\u00e7l\u00fc tepki verir. Son 2. \u00e7eyrek 2025 s\u00fcrprizi, beklentileri a\u015f\u0131nca neler oldu\u011funu g\u00f6steriyor\u2014an\u0131nda \u00e7ift haneli hareketler. Olumsuz sonu\u00e7lar k\u0131sa vadede s\u0131k\u0131nt\u0131 yarat\u0131r ancak hisse genellikle haftalar i\u00e7inde pazar liderli\u011fi sayesinde toparlan\u0131r.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h2> <p>Illumina hisseleri bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131, \u015fu anda <strong>y\u0131lba\u015f\u0131ndan bu yana %23,97 d\u00fc\u015f\u00fc\u015fte<\/strong> ancak son d\u00f6nemde g\u00fc\u00e7lenme g\u00f6steriyor:<\/p> <p><strong>\u015eubat<\/strong>: 102,30 $ (y\u0131ll\u0131k rapor hayal k\u0131r\u0131kl\u0131\u011f\u0131)<br\/> <strong>Mart<\/strong>: 96,80 $ (NIH finansman endi\u015feleri ara\u015ft\u0131rma segmentini etkiledi)<br\/> <strong>Nisan<\/strong>: 92,50 $ (Roche'dan rekabet bask\u0131s\u0131)<br\/> <strong>May\u0131s<\/strong>: 94,50 $ (1. \u00e7eyrek kazan\u00e7 stabilizasyonu)<br\/> <strong>Haziran<\/strong>: 95,41 $ (X sarf malzemeleri art\u0131\u015f\u0131 ba\u015flad\u0131)<br\/> <strong>Temmuz<\/strong>: 100,34 $ (2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi heyecan\u0131)<br\/> <strong>A\u011fustos<\/strong>: 100,53 $ (mevcut konsolidasyon)<\/p> <p>Son toparlanman\u0131n sebebi nedir? Klinik segment b\u00fcy\u00fcmesi h\u0131zland\u0131 ve dizileme sarf malzemelerinin %60'\u0131n\u0131 olu\u015fturdu, ayr\u0131ca X-serisi platformu ba\u015flang\u0131\u00e7taki benimseme zorluklar\u0131n\u0131n ard\u0131ndan nihayet ivme kazand\u0131.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 115-125 $ (klinik ivme + SomaLogic sat\u0131n al\u0131m\u0131) \u2192 <strong>AL<\/strong><\/li> <li><strong>2026<\/strong>: 130-145 $ (proteomik geni\u015flemesi + FDA onaylar\u0131)<\/li> <li><strong>2028<\/strong>: 160-180 $ (uzun okuma dizileme hakimiyeti)<\/li> <li><strong>2030<\/strong>: 200-240 $ (k\u00fcresel genomik pazar patlamas\u0131)<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: G\u00fc\u00e7l\u00fc uzun vadeli tutma potansiyeli. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar 3 Kas\u0131m civar\u0131ndaki kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri izlemeli.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon sorunlar\u0131<\/strong>: \u00c7in ve ABD ticaret gerilimleri belirsizlik yarat\u0131yor (<a href=\"https:\/\/www.ainvest.com\/news\/illumina-stock-remains-undervalued-regulatory-risks-2508\/\">Reg\u00fclasyon Riskleri Analizi<\/a>)<\/li> <li><strong>Artan rekabet<\/strong>: Roche'un yeni \u00fcr\u00fcnleri pazar pay\u0131 \u00e7al\u0131yor<\/li> <li><strong>NIH finansman kesintileri<\/strong>: Ara\u015ft\u0131rma kurumlar\u0131 b\u00fct\u00e7eleri s\u0131k\u0131la\u015ft\u0131r\u0131yor<\/li> <li><strong>Fiyat bask\u0131s\u0131<\/strong>: X-platformuna ge\u00e7i\u015f marjlar\u0131 etkiliyor<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Klinik patlama<\/strong>: Sarf malzemelerin %60'\u0131 art\u0131k klinik\u2014istikrarl\u0131, tekrarlayan gelir (<a href=\"https:\/\/www.youtube.com\/watch?v=puUpv1O0kZY\">2. \u00c7eyrek 2025 Analizi<\/a>)<\/li> <li><strong>SomaLogic sat\u0131n al\u0131m\u0131<\/strong>: 350 milyon dolarl\u0131k anla\u015fma y\u00fcksek marjl\u0131 proteomik alana geni\u015fliyor<\/li> <li><strong>Marj geni\u015flemesi<\/strong>: Zorluklara ra\u011fmen 160 baz puan iyile\u015fme<\/li> <li><strong>X-serisi ivmesi<\/strong>: Nihayet benimseme d\u00f6n\u00fcm noktas\u0131na ula\u015f\u0131ld\u0131<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Ortalama maliyet y\u00f6ntemi<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k k\u00fc\u00e7\u00fck al\u0131mlar yap\u0131n<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: 3 Kas\u0131m al\u0131m f\u0131rsatlar\u0131 yaratabilir<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Genomik 10+ y\u0131ll\u0131k bir hikaye, \u00e7eyreklik ticaret de\u011fil<\/li> <li><strong>Esprili yakla\u015f\u0131m<\/strong>: \"ILMN ticareti DNA okumak gibidir\u2014bazen mutasyonlar olur ama genetik kod her zaman galip gelir\"<\/li> <\/ol> <h2>\u2705 Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ticaret platformu se\u00e7in<\/td><td>ABD hisseleri i\u00e7in NASDAQ eri\u015fimi sunmal\u0131<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"ILMN\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emri ani fiyat s\u0131\u00e7ramalar\u0131ndan korur<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretlerini kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu izleyin<\/td><td>Kazan\u00e7 volatilitesi i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <tr><td>7<\/td><td>Par\u00e7al\u0131 hisse d\u00fc\u015f\u00fcn\u00fcn<\/td><td>Daha k\u00fc\u00e7\u00fck miktarlarla pozisyon al\u0131n<\/td><\/tr> <tr><td>8<\/td><td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td><td>K\u00e2r hedeflerinizi ve zarar durdur seviyelerinizi bilin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Genomik Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>Pocket Option genomik devrime kat\u0131lmay\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>5 $ minimum depozito<\/strong>\u2014Illumina ile stratejileri b\u00fcy\u00fck sermaye riske atmadan test edin<\/li> <li><strong>1 dakikal\u0131k do\u011frulama<\/strong>\u2014herhangi bir kimlik y\u00fckleyin ve piyasa saatlerinde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong>\u2014k\u00e2rlar\u0131n\u0131z\u0131 kripto, e-c\u00fczdan veya banka transferi ile al\u0131n<\/li> <li><strong>Ger\u00e7ek zamanl\u0131 NASDAQ verisi<\/strong>\u2014ILMN'i ger\u00e7ek piyasa fiyatlar\u0131 ve y\u00fcr\u00fctme ile i\u015flem yap\u0131n<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Illumina: Genomiklerin Sessiz Devi<\/h2> <p>Illumina, genom dizileme d\u00fcnyas\u0131nda \u00f6nde gelir; teknolojileri sayesinde genom dizileme maliyetlerini 150.000 dolardan 200 dolara d\u00fc\u015f\u00fcrd\u00fc\u2014%99,9 azalma ile t\u0131pta devrim yarat\u0131yor. Dizileme makinelerinin \u00f6tesinde, SomaLogic sat\u0131n al\u0131m\u0131yla proteomik alana geni\u015fliyor ve 2026 i\u00e7in 5 bazl\u0131 dizileme teknolojisi geli\u015ftiriyorlar.<\/p> <p><strong>2025 E\u011flenceli Bilgi<\/strong>: Illumina'n\u0131n yeni multiomik platformu genomik, mekansal veri, tek h\u00fccre, CRISPR ve metilasyon analizlerini tek bir sistemde yapabiliyor. \u0130nsan biyolojisinin \"Google Haritalar\u0131n\u0131\" in\u015fa ediyorlar!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Illumina Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla Illumina, Inc. (ILMN) NASDAQ&#8217;ta <strong>100,53 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>3 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014Illumina&#8217;n\u0131n 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu raporlar hisse senedini dramatik \u015fekilde hareket ettirmi\u015ftir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131n\u0131n ILMN Hissesini Hareket Ettirme \u015eekli<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>31 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>98,15 $<\/td>\n<td><strong>%17,8 EPS s\u00fcrprizi<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1 May\u0131s 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>94,50 $<\/td>\n<td>%5,2 art\u0131\u015f (istikrarl\u0131 b\u00fcy\u00fcme)<\/td>\n<\/tr>\n<tr>\n<td>12 \u015eubat 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>102,30 $<\/td>\n<td>%3,8 d\u00fc\u015f\u00fc\u015f (gelir hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>4 Kas\u0131m 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>105,60 $<\/td>\n<td>%6,1 art\u0131\u015f (klinik b\u00fcy\u00fcme)<\/td>\n<\/tr>\n<tr>\n<td>8 A\u011fustos 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>108,90 $<\/td>\n<td>%4,2 d\u00fc\u015f\u00fc\u015f (finansman endi\u015feleri)<\/td>\n<\/tr>\n<tr>\n<td>9 May\u0131s 2024<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>112,40 $<\/td>\n<td>%3,5 art\u0131\u015f (yeni \u00fcr\u00fcn lansman\u0131)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Analizi<\/strong>: Illumina genellikle kazan\u00e7 s\u00fcrprizlerine g\u00fc\u00e7l\u00fc tepki verir. Son 2. \u00e7eyrek 2025 s\u00fcrprizi, beklentileri a\u015f\u0131nca neler oldu\u011funu g\u00f6steriyor\u2014an\u0131nda \u00e7ift haneli hareketler. Olumsuz sonu\u00e7lar k\u0131sa vadede s\u0131k\u0131nt\u0131 yarat\u0131r ancak hisse genellikle haftalar i\u00e7inde pazar liderli\u011fi sayesinde toparlan\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>Illumina hisseleri bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131, \u015fu anda <strong>y\u0131lba\u015f\u0131ndan bu yana %23,97 d\u00fc\u015f\u00fc\u015fte<\/strong> ancak son d\u00f6nemde g\u00fc\u00e7lenme g\u00f6steriyor:<\/p>\n<p><strong>\u015eubat<\/strong>: 102,30 $ (y\u0131ll\u0131k rapor hayal k\u0131r\u0131kl\u0131\u011f\u0131)<br \/> <strong>Mart<\/strong>: 96,80 $ (NIH finansman endi\u015feleri ara\u015ft\u0131rma segmentini etkiledi)<br \/> <strong>Nisan<\/strong>: 92,50 $ (Roche&#8217;dan rekabet bask\u0131s\u0131)<br \/> <strong>May\u0131s<\/strong>: 94,50 $ (1. \u00e7eyrek kazan\u00e7 stabilizasyonu)<br \/> <strong>Haziran<\/strong>: 95,41 $ (X sarf malzemeleri art\u0131\u015f\u0131 ba\u015flad\u0131)<br \/> <strong>Temmuz<\/strong>: 100,34 $ (2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi heyecan\u0131)<br \/> <strong>A\u011fustos<\/strong>: 100,53 $ (mevcut konsolidasyon)<\/p>\n<p>Son toparlanman\u0131n sebebi nedir? Klinik segment b\u00fcy\u00fcmesi h\u0131zland\u0131 ve dizileme sarf malzemelerinin %60&#8217;\u0131n\u0131 olu\u015fturdu, ayr\u0131ca X-serisi platformu ba\u015flang\u0131\u00e7taki benimseme zorluklar\u0131n\u0131n ard\u0131ndan nihayet ivme kazand\u0131.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 115-125 $ (klinik ivme + SomaLogic sat\u0131n al\u0131m\u0131) \u2192 <strong>AL<\/strong><\/li>\n<li><strong>2026<\/strong>: 130-145 $ (proteomik geni\u015flemesi + FDA onaylar\u0131)<\/li>\n<li><strong>2028<\/strong>: 160-180 $ (uzun okuma dizileme hakimiyeti)<\/li>\n<li><strong>2030<\/strong>: 200-240 $ (k\u00fcresel genomik pazar patlamas\u0131)<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: G\u00fc\u00e7l\u00fc uzun vadeli tutma potansiyeli. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar 3 Kas\u0131m civar\u0131ndaki kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri izlemeli.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon sorunlar\u0131<\/strong>: \u00c7in ve ABD ticaret gerilimleri belirsizlik yarat\u0131yor (<a href=\"https:\/\/www.ainvest.com\/news\/illumina-stock-remains-undervalued-regulatory-risks-2508\/\">Reg\u00fclasyon Riskleri Analizi<\/a>)<\/li>\n<li><strong>Artan rekabet<\/strong>: Roche&#8217;un yeni \u00fcr\u00fcnleri pazar pay\u0131 \u00e7al\u0131yor<\/li>\n<li><strong>NIH finansman kesintileri<\/strong>: Ara\u015ft\u0131rma kurumlar\u0131 b\u00fct\u00e7eleri s\u0131k\u0131la\u015ft\u0131r\u0131yor<\/li>\n<li><strong>Fiyat bask\u0131s\u0131<\/strong>: X-platformuna ge\u00e7i\u015f marjlar\u0131 etkiliyor<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Klinik patlama<\/strong>: Sarf malzemelerin %60&#8217;\u0131 art\u0131k klinik\u2014istikrarl\u0131, tekrarlayan gelir (<a href=\"https:\/\/www.youtube.com\/watch?v=puUpv1O0kZY\">2. \u00c7eyrek 2025 Analizi<\/a>)<\/li>\n<li><strong>SomaLogic sat\u0131n al\u0131m\u0131<\/strong>: 350 milyon dolarl\u0131k anla\u015fma y\u00fcksek marjl\u0131 proteomik alana geni\u015fliyor<\/li>\n<li><strong>Marj geni\u015flemesi<\/strong>: Zorluklara ra\u011fmen 160 baz puan iyile\u015fme<\/li>\n<li><strong>X-serisi ivmesi<\/strong>: Nihayet benimseme d\u00f6n\u00fcm noktas\u0131na ula\u015f\u0131ld\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Ortalama maliyet y\u00f6ntemi<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k k\u00fc\u00e7\u00fck al\u0131mlar yap\u0131n<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: 3 Kas\u0131m al\u0131m f\u0131rsatlar\u0131 yaratabilir<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Genomik 10+ y\u0131ll\u0131k bir hikaye, \u00e7eyreklik ticaret de\u011fil<\/li>\n<li><strong>Esprili yakla\u015f\u0131m<\/strong>: &#8220;ILMN ticareti DNA okumak gibidir\u2014bazen mutasyonlar olur ama genetik kod her zaman galip gelir&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ticaret platformu se\u00e7in<\/td>\n<td>ABD hisseleri i\u00e7in NASDAQ eri\u015fimi sunmal\u0131<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;ILMN&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emri ani fiyat s\u0131\u00e7ramalar\u0131ndan korur<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Kazan\u00e7 volatilitesi i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Par\u00e7al\u0131 hisse d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>Daha k\u00fc\u00e7\u00fck miktarlarla pozisyon al\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td>\n<td>K\u00e2r hedeflerinizi ve zarar durdur seviyelerinizi bilin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Genomik Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>Pocket Option genomik devrime kat\u0131lmay\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>5 $ minimum depozito<\/strong>\u2014Illumina ile stratejileri b\u00fcy\u00fck sermaye riske atmadan test edin<\/li>\n<li><strong>1 dakikal\u0131k do\u011frulama<\/strong>\u2014herhangi bir kimlik y\u00fckleyin ve piyasa saatlerinde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong>\u2014k\u00e2rlar\u0131n\u0131z\u0131 kripto, e-c\u00fczdan veya banka transferi ile al\u0131n<\/li>\n<li><strong>Ger\u00e7ek zamanl\u0131 NASDAQ verisi<\/strong>\u2014ILMN&#8217;i ger\u00e7ek piyasa fiyatlar\u0131 ve y\u00fcr\u00fctme ile i\u015flem yap\u0131n<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Illumina: Genomiklerin Sessiz Devi<\/h2>\n<p>Illumina, genom dizileme d\u00fcnyas\u0131nda \u00f6nde gelir; teknolojileri sayesinde genom dizileme maliyetlerini 150.000 dolardan 200 dolara d\u00fc\u015f\u00fcrd\u00fc\u2014%99,9 azalma ile t\u0131pta devrim yarat\u0131yor. Dizileme makinelerinin \u00f6tesinde, SomaLogic sat\u0131n al\u0131m\u0131yla proteomik alana geni\u015fliyor ve 2026 i\u00e7in 5 bazl\u0131 dizileme teknolojisi geli\u015ftiriyorlar.<\/p>\n<p><strong>2025 E\u011flenceli Bilgi<\/strong>: Illumina&#8217;n\u0131n yeni multiomik platformu genomik, mekansal veri, tek h\u00fccre, CRISPR ve metilasyon analizlerini tek bir sistemde yapabiliyor. \u0130nsan biyolojisinin &#8220;Google Haritalar\u0131n\u0131&#8221; in\u015fa ediyorlar!<\/p>\n"},"faq":[{"question":"Illumina hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"ILMN\" sembol\u00fc ile arama yap\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in, i\u015flemi onaylay\u0131n ve pozisyonunuzu izleyin."},{"question":"Illumina'n\u0131n pazar liderli\u011fi nedir?","answer":"Illumina, klinik genomikte %90'dan fazla pazar pay\u0131na sahip lider bir genomik dizileme \u015firketidir."},{"question":"2025 i\u00e7in Illumina hissesi fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda fiyat\u0131n 115-125 $ aras\u0131nda olmas\u0131 bekleniyor, uzun vadede ise 2030'a kadar 200-240 $ aral\u0131\u011f\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor."},{"question":"Illumina hissesi al\u0131rken hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon sorunlar\u0131, artan rekabet, NIH finansman kesintileri ve fiyat bask\u0131s\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar i\u00e7in yat\u0131r\u0131m \u00f6nerileri nelerdir?","answer":"D\u00fczenli k\u00fc\u00e7\u00fck al\u0131mlar yaparak ortalama maliyet y\u00f6ntemi uygulamak, kazan\u00e7 uyar\u0131lar\u0131 kurmak ve uzun vadeli d\u00fc\u015f\u00fcnmek \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Illumina hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"ILMN\" sembol\u00fc ile arama yap\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in, i\u015flemi onaylay\u0131n ve pozisyonunuzu izleyin."},{"question":"Illumina'n\u0131n pazar liderli\u011fi nedir?","answer":"Illumina, klinik genomikte %90'dan fazla pazar pay\u0131na sahip lider bir genomik dizileme \u015firketidir."},{"question":"2025 i\u00e7in Illumina hissesi fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda fiyat\u0131n 115-125 $ aras\u0131nda olmas\u0131 bekleniyor, uzun vadede ise 2030'a kadar 200-240 $ aral\u0131\u011f\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor."},{"question":"Illumina hissesi al\u0131rken hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon sorunlar\u0131, artan rekabet, NIH finansman kesintileri ve fiyat bask\u0131s\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar i\u00e7in yat\u0131r\u0131m \u00f6nerileri nelerdir?","answer":"D\u00fczenli k\u00fc\u00e7\u00fck al\u0131mlar yaparak ortalama maliyet y\u00f6ntemi uygulamak, kazan\u00e7 uyar\u0131lar\u0131 kurmak ve uzun vadeli d\u00fc\u015f\u00fcnmek \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T15:32:45+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T15:32:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/\",\"name\":\"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-20T15:32:45+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/","og_locale":"tr_TR","og_type":"article","og_title":"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T15:32:45+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T15:32:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/","name":"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-20T15:32:45+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-illumina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Illumina, Inc. (ILMN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Illumina, Inc. (ILMN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":341713,"slug":"how-to-buy-illumina","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Illumina, Inc. (ILMN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Illumina, Inc. (ILMN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-illumina\/"},"pt_AA":{"locale":"pt_AA","id":341710,"slug":"how-to-buy-illumina","post_title":"Como comprar a\u00e7\u00f5es da Illumina, Inc. (ILMN) - Investimento em a\u00e7\u00f5es da Illumina, Inc. (ILMN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-illumina\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=341715"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341715\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=341715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=341715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=341715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}